| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 20, 2024 | Option Exercise | $11.97 | 10,945 | 131,012 | 18,303,800 | Sep 24, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 23, 2024 | Option Exercise | $11.97 | 498,539 | 5,967,512 | 17,372,004 | Sep 24, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 23, 2024 | Option Exercise | $3.85 | 1,550,000 | 5,967,500 | 19,853,800 | Sep 24, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 23, 2024 | Sale | $11.79 | 1,983,257 | 23,382,600 | 17,870,543 | Sep 24, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Aug 20, 2024 | Option Exercise | $11.48 | 10,947 | 125,672 | 18,314,745 | Aug 22, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jul 20, 2024 | Option Exercise | $11.00 | 10,945 | 120,395 | 1,120,871 | Jul 25, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jun 20, 2024 | Option Exercise | $10.80 | 10,945 | 118,206 | 1,131,816 | Jun 24, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | May 20, 2024 | Option Exercise | $11.37 | 10,945 | 124,445 | 1,142,761 | May 22, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Apr 20, 2024 | Option Exercise | $10.46 | 10,945 | 114,485 | 1,153,706 | Apr 23, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 30, 2024 | Option Exercise | $10.54 | 215,991 | 2,276,545 | 1,164,651 | Apr 02, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 20, 2024 | Option Exercise | $10.01 | 10,945 | 109,559 | 990,063 | Mar 22, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Feb 20, 2024 | Option Exercise | $11.54 | 10,945 | 126,305 | 1,001,008 | Feb 22, 2024, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jan 20, 2024 | Option Exercise | $10.35 | 10,945 | 113,281 | 1,011,953 | Jan 23, 2024, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Dec 27, 2023 | Option Exercise | $11.58 | 22,043 | 255,258 | 1,022,898 | Dec 29, 2023, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Dec 20, 2023 | Option Exercise | $9.96 | 10,945 | 109,012 | 1,006,488 | Dec 22, 2023, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Nov 22, 2023 | Option Exercise | $8.68 | 11,318 | 98,240 | 1,017,433 | Nov 27, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Oct 24, 2023 | Option Exercise | $8.99 | 12,489 | 112,276 | 1,028,751 | Oct 26, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 28, 2023 | Option Exercise | $12.67 | 10,243 | 129,779 | 1,041,240 | Sep 29, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 22, 2023 | Option Exercise | $10.19 | 11,227 | 114,403 | 1,033,721 | Sep 26, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Aug 28, 2023 | Option Exercise | $11.25 | 6,784 | 76,320 | 1,044,948 | Aug 29, 2023, 09:31 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Aug 22, 2023 | Option Exercise | $10.83 | 11,015 | 119,292 | 1,039,644 | Aug 24, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Aug 02, 2023 | Option Exercise | $11.79 | 11,749 | 138,521 | 1,050,659 | Aug 03, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jul 24, 2023 | Option Exercise | $10.99 | 11,146 | 122,495 | 1,039,259 | Jul 26, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jun 22, 2023 | Option Exercise | $10.01 | 10,863 | 108,739 | 1,050,405 | Jun 26, 2023, 09:31 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | May 31, 2023 | Option Exercise | $9.09 | 30,266 | 275,118 | 1,061,268 | May 31, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | May 23, 2023 | Option Exercise | $9.58 | 18,972 | 181,752 | 1,038,253 | May 25, 2023, 09:31 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Apr 20, 2023 | Option Exercise | $8.80 | 19,375 | 170,500 | 1,057,225 | Apr 24, 2023, 09:28 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 23, 2023 | Option Exercise | $7.30 | 18,563 | 135,510 | 1,076,600 | Mar 27, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Feb 22, 2023 | Option Exercise | $8.43 | 14,471 | 121,991 | 1,095,163 | Feb 24, 2023, 09:30 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jan 24, 2023 | Option Exercise | $8.56 | 15,594 | 133,485 | 1,109,634 | Jan 26, 2023, 09:01 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Dec 23, 2022 | Option Exercise | $7.10 | 19,408 | 137,797 | 1,125,228 | Dec 28, 2022, 09:31 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Nov 20, 2022 | Option Exercise | $5.00 | 19,373 | 96,865 | 1,144,636 | Nov 22, 2022, 06:31 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Oct 25, 2022 | Sale | $4.40 | 19,276 | 84,814 | 1,164,009 | Oct 27, 2022, 06:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Sep 23, 2022 | Sale | $3.07 | 21,053 | 64,633 | 1,183,285 | Sep 27, 2022, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Aug 24, 2022 | Sale | $3.71 | 20,009 | 74,233 | 1,204,338 | Aug 26, 2022, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jul 25, 2022 | Sale | $4.33 | 20,455 | 88,570 | 1,224,347 | Jul 27, 2022, 09:08 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Jun 23, 2022 | Sale | $4.34 | 19,855 | 86,171 | 1,244,802 | Jun 27, 2022, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | May 20, 2022 | Sale | $3.70 | 139,791 | 517,227 | 1,264,657 | May 24, 2022, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Apr 25, 2022 | Sale | $3.84 | 8,509 | 32,675 | 1,404,448 | Apr 27, 2022, 07:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 30, 2022 | Option Exercise | $4.74 | 25,254 | 119,704 | 1,412,957 | Apr 01, 2022, 06:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 30, 2022 | Sale | $4.84 | 33,686 | 163,040 | 1,438,211 | Apr 01, 2022, 06:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 25, 2022 | Sale | $5.06 | 35,386 | 179,053 | 1,471,897 | Mar 29, 2022, 06:29 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 18, 2022 | Sale | $5.13 | 82,006 | 420,691 | 1,507,283 | Mar 22, 2022, 09:00 PM | |
| ROIV | Roivant Sciences Ltd. | Gline Matthew | CEO | Mar 07, 2022 | Sale | $5.52 | 92,324 | 509,628 | 1,589,289 | Mar 09, 2022, 09:45 PM |
Menu